Related Experiment Video
Updated: Oct 10, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
MALAT1 downregulation is associated with polycystic ovary syndrome via binding with MDM2 and repressing P53
Yan Li1, Yungai Xiang1, Yuxia Song1
1Reproductive Center, The Second Affiliated Hospital of Zhengzhou University, 450014, No. 2 Jingba Road, Zhengzhou, Henan, China.
Abstract:
Polycystic ovary syndrome (PCOS) is a metabolic disorder of the reproductive system that affects 6-20% women of reproductive age. Multiple coding and non-coding genes were found to be affected in patients with PCOS, including MALAT1, an 8.7 kb long non-coding RNA. MALAT1 has been found to interact with miRNAs in granulosa cells (GCs); however, its binding proteins in GCs are still unknown. In this study, MALAT1 binding proteins in primary GCs were recruited by RNA antisense purification (RAP) assay and identified by mass spectrometry. The interaction between MALAT1 and proteins was examined by the PAR-CLIP assay and immunofluorescence. Functional studies were performed using the human granulosa-like tumor cell line (KGN) and primary granulosa cells. We identified that MALAT1 interacted with MDM2 and PARP1 in the cell nucleus. MDM2 binds to the 3' segment of MALAT1, containing the ENE domain through the ring finger domain. Knockdown of MALAT1 in GCs increased p53 protein levels by repressing p53 ubiquitination and degradation. MALAT1 promoted the binding between P53 and MDM2, which further boosted P53 proteasome dependent degradation. Knockdown of MALAT1 in KGN cells and primary GCs increased apoptosis and reduced proliferation.
Insights
Polycystic ovary syndrome (PCOS) involves the long non-coding RNA MALAT1 interacting with proteins MDM2 and PARP1. MALAT1 knockdown in granulosa cells impacts p53 levels, affecting cell apoptosis and proliferation in PCOS.
Area of Science:
- Reproductive biology
- Molecular genetics
- Cellular mechanisms
Background:
- Polycystic ovary syndrome (PCOS) affects 6-20% of reproductive-aged women, characterized by metabolic and reproductive dysfunction.
- Long non-coding RNAs, such as MALAT1, are implicated in PCOS pathogenesis.
- The binding proteins of MALAT1 in human granulosa cells (GCs) remain unidentified, hindering understanding of its role.
Purpose of the Study:
- To identify MALAT1 binding proteins in primary GCs.
- To elucidate the functional role of MALAT1-protein interactions in GCs.
- To investigate the impact of MALAT1 on p53 regulation and granulosa cell function.
Main Methods:
- RNA antisense purification (RAP) assay coupled with mass spectrometry to identify MALAT1 binding proteins.
- PAR-CLIP assay and immunofluorescence to confirm MALAT1-protein interactions.
- Functional studies in KGN cells and primary GCs involving MALAT1 knockdown.
Main Results:
- MALAT1 was found to interact with MDM2 and PARP1 within the nucleus of GCs.
- MDM2 binds to the ENE domain of MALAT1 via its ring finger domain.
- MALAT1 knockdown increased p53 protein levels by inhibiting p53 ubiquitination and degradation, and promoted p53-MDM2 binding, enhancing p53 proteasomal degradation.
Conclusions:
- MALAT1 plays a regulatory role in GCs by interacting with MDM2 and PARP1.
- MALAT1 influences p53 stability and degradation pathways.
- MALAT1 knockdown leads to increased apoptosis and reduced proliferation in GCs, suggesting a role in PCOS pathophysiology.
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
MicroRNAs
Negative Regulator Molecules
Oogenesis
Epigenetic Regulation

